Covid-19 (Temas de Saúde Pública)
[Preprint] “Long Covid”: sintomas persistentes após infecção por SARS-CoV-2 em uma amostra aleatória de 508.707 pessoas da comunidade.
13 Jul, 2021 | 11:27hComentário: Study explores the prevalence of long COVID in England – News Medical
OMS alerta quanto à mistura e à combinação de vacinas contra a COVID.
13 Jul, 2021 | 11:26hWHO warns against mixing and matching COVID vaccines – Reuters
Comentário: WHO cautions data still limited on mixing COVID-19 vaccines, but Canadian officials say it’s OK – CTV News
Relacionado: Germany issues world’s strongest recommendation for mixing Covid-19 vaccines. E [Preprint] Mixing Covid jabs has good immune response, study finds – “The Com-Cov trial looked at the efficacy of either two doses of Pfizer, two of AstraZeneca, or one of them followed by the other. All combinations worked well, priming the immune system”. E Perspective | Can I get AstraZeneca now and Pfizer later? Why mixing and matching COVID vaccines could help solve many rollout problems. E RCT: Mixing 2 different Covid vaccines is associated with increased risk of side effects. E Should you mix and match COVID-19 vaccines? Scientists are seeking answers
Comentário no Twitter
The World Health Organization's chief scientist on Monday advised against people mixing and matching COVID-19 vaccines from different manufacturers, calling it a "dangerous trend" since there was little data available about the health impact. https://t.co/Oog6fWDSMz
— Reuters Health (@Reuters_Health) July 13, 2021
Debate Pró-Con | Deveríamos postergar a vacinação contra Covid-19 em crianças?
13 Jul, 2021 | 11:25hShould we delay covid-19 vaccination in children? – The BMJ
Comunicado de imprensa: Should we delay COVID-19 vaccination in children? – British Medical Journal
Comentário no Twitter
Covid-19 vaccines in adults have been remarkably effective. There is good reason to expect that the same will be true in children.
A group of authors discuss the pros and cons of vaccinating children against covid-19 https://t.co/TOEI67YPeH
— The BMJ (@bmj_latest) July 9, 2021
Casos extremamente raros de Guillain-Barré relatados com a vacina da Johnson & Johnson contra a Covid-19.
13 Jul, 2021 | 11:24hJ&J’s Covid-19 vaccine may trigger neurological condition in rare cases, FDA says – STAT
Ver também: Johnson & Johnson Vaccine Is Linked To Neurological Disorder In Extremely Rare Cases – NPR E F.D.A. Attaches Warning of Rare Nerve Syndrome to Johnson & Johnson Vaccine – The New York Times
[Preprint] Estudo confirma o risco extremamente baixo de morte por Covid-19 em crianças – “99,995% das crianças e jovens com teste positivo para SARS-CoV-2 sobreviveram.”
12 Jul, 2021 | 11:39hComentários: Risks of severe illness in children from COVID-19 shown to be very low in largest study yet – University of Liverpool E Covid: Children’s extremely low risk confirmed by study – BBC
Estudo relacionado feito pelo mesmo grupo (preprint): Risk factors for intensive care admission and death amongst children and young people admitted to hospital with COVID-19 and PIMS-TS in England during the first pandemic year – medRxiv
Nova orientação do CDC para a prevenção da COVID-19 em escolas de educação infantil afirma que a prioridade é o retorno seguro ao ensino presencial.
12 Jul, 2021 | 11:38hComentários: Updated CDC schools guidance prioritizes in-person learning, even if all Covid-19 safety measures aren’t in place – CNN E The C.D.C. Issues New School Guidance, With Emphasis on Full Reopening – The New York Times E New CDC guidance says fully vaccinated teachers and students don’t need to wear masks indoors – CNBC E CDC calls for reopening schools fully, recommends masking – CIDRAP
Relacionado: COVID and schools: the evidence for reopening safely – Nature
Pfizer afirma que é hora de um reforço (terceira dose) na vacina contra a Covid; FDA e CDC dizem que ainda não.
12 Jul, 2021 | 11:35hPfizer says it’s time for a Covid booster; FDA and CDC say not so fast – CNN
Ver também: CDC, FDA contradict Pfizer on COVID-19 vaccine booster – CIDRAP E Do I need a COVID-19 booster shot? 6 questions answered on how to stay protected – The Conversation E Pfizer suggests booster shots will be needed this year, but government officials say science will dictate the timing – The Washington Post E Pfizer to seek OK for 3rd vaccine dose; shots still protect – Associated Press E Citing the Delta Variant, Pfizer Will Pursue Booster Shots and a New Vaccine – The New York Times (poucos artigos gratuitos por mês) E Question open on need for COVID booster shot, data awaited, WHO says – Reuters
Public Health England | As vacinas contra COVID-19 são altamente eficazes em grupos de alto risco.
12 Jul, 2021 | 11:34hCOVID-19 vaccines highly effective in clinical risk groups – Public Health England
Comentário: Covid vaccines do work well in clinically vulnerable – BBC E Public Health England says Pfizer, AstraZeneca vaccines effective in high-risk groups – Reuters
Comentário no Twitter (fio – clique para saber mais)
NEWS: #COVID19 #vaccines highly effective in clinical risk groupshttps://t.co/mkVnxTqOrJ pic.twitter.com/M6Me98SRln
— Public Health England (@PHE_uk) July 9, 2021
Lambda, a mais nova variante de interesse da OMS, está agora em 29 países.
12 Jul, 2021 | 11:33hLambda, the Newest WHO Variant of Interest, is Now in 29 Countries – Health Policy Watch
É possível aplicar doses menores das vacinas já existentes contra a Covid para inocular mais pessoas? Os especialistas estão divididos.
12 Jul, 2021 | 11:32hCan we stretch existing Covid vaccines to inoculate more people? Experts are divided – STAT
Ver também: Quarter-dose of Moderna COVID vaccine still rouses a big immune response